Regeneron Patent Targeted In New Post-Grant Review Petition

(January 12, 2021, 1:52 PM EST) -- ALEXANDRIA, Va. — The maker of an antibody cocktail that recently won emergency use authorization for the treatment of COVID-19 is being challenged on a different front before the Patent Trial...

To view the full article, register now.